3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Leukemia, Myeloid, Acute
4
Congenital Abnormalities
4
Leukemia
3
Carcinoma, Hepatocellular
3
Breast Neoplasms
3
Leukemia, Myelomonocytic, Acute
2
Leukemia, Monocytic, Acute
2
Leukemia, Megakaryoblastic, Acute
2
Leukemia, Erythroblastic, Acute
2
Head and Neck Neoplasms
2
Stomach Neoplasms
1
Sarcoma
1
Prostatic Neoplasms
1
Myeloproliferative Disorders
1
Lymphoma
1
Lymphedema
1
Lung Neoplasms
1
Liver Neoplasms
1
Leukemia, Myelomonocytic, Chronic
1
Hematologic Neoplasms
1
Fibrosis
1
Esophageal Neoplasms
1
Deglutition Disorders
1
Cardiovascular Diseases
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
Radiotherapy
2
Exercise
2
Deglutition
2
Cisplatin
2
Carboplatin
2
Brachytherapy
2
Acupuncture Therapy
2
tislelizumab
1
epigallocatechin gallate
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
auricularum
1
Tablets
1
Standard of Care
1
Resistance Training
1
Range of Motion, Articular
1
Radiotherapy, Intensity-Modulated
1
Radiation
1
Pravastatin
1
Paclitaxel
1
Niacinamide
1
Musculoskeletal Manipulations
1
Lead
1
Hyaluronic Acid
1
Gastropexy
1
Fundoplication
1
Fluorouracil
1
Fibroblast Growth Factor 7
1
Esophagectomy
1
Endoscopy, Digestive System
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Deglutition Disorders
×
Pravastatin
×
Clear all
NCT07217938
2026-03-03
TRADstat
Peter MacCallum Cancer Centre, Australia
Phase 2
Recruiting
48 enrolled